References
- Gupta PK, Hung CT. (1989). Albumin microspheres. II: applications in drug delivery. J Microencapsul 6:463–72
- Kanke M, Simmons GH, Weiss DL, et al. (1980). Clearance of 141Ce-labeled microspheres from blood and distribution in specific organs following intravenous and intra arterial administration in beagle dogs. J Pharm Sci 67:755–65
- Kawaguchi H. (2000). Functional polymer microspheres. Prog Polym Sci 25:1171–210
- Kim SY, Lee YM. (2001). Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. Biomaterials 22:2049–56
- Lin X, Zhang B, Zhang K, et al. (2012). Preclinical evaluations of norcantharidin-loaded intravenous lipid microspheres with low toxicity. Expert Opin Drug Deliv 9:1449–62
- Liu XH, Blazsek I, Comisso M, et al. (1995). Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells. Eur J Cancer 31A:953–63
- Longo W, Iwata H, Lindheimer TA, Goldberg EP. (1982). Preparation of hydrophilic albumin microspheres using polymeric dispersing agents. J Pharm Sci 71:1323–8
- Longo WE, Goldberg EP. (1985). Hydrophilic albumin microspheres. Meth Enzymol 112:18–26
- Mathew ST, Devi SG, Prasanth VV, Vinod B. (2009). Formulation and in vitro–in vivo evaluation of ketoprofen-loaded albumin microspheres for intramuscular administration. J Microencapsul 26:456–69
- Nanji AA, Su GL, Laposata M, French SW. (2002). Pathogenesis of alcoholic liver disease–recent advances. Alcohol Clin Exp Res 26:731–6
- Okada H, Toguchi H. (1995). Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 12:1–99
- Shi B, Fang C, You MX. (2005). Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vitro drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumor bearing mice. Colloid Polym Sci 283:954–67
- Sree H, Shobha R. (2006). Drug targeting to lungs by way of microspheres. Arch Pharm Res 29:598–604
- Tagwireyi D, Ball DE, Loga PJ, Moyo S. (2000). Cantharidin poisoning due to “Blister beetle” ingestion. Toxicon 38:1865–9
- Wang GS. (1989). Medical uses of mylabris in ancient China and recent studies. J Ethnopharmacol 26:147–62
- Wang S, Guo S. (2008a). Disodium norcantharidate-loaded poly(epsilon-caprolactone) microspheres II. Modification of morphology and release behavior. Int J Pharm 353:15–20
- Wang S, Guo S. (2008b). Formation mechanism and release behavior of poly(epsilon-caprolactone) microspheres containing disodium norcantharidate. Eur J Pharm Biopharm 69:1176–81
- Wang S, Guo S, Cheng L. (2008). Disodium norcantharidate loaded poly(epsilon-caprolactone) microspheres I. Preparation and evaluation. Int J Pharm 350:130–7
- Yi SN, Wass J, Vincent P, Iland H. (1991). Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro. Leuk Res 15:883–6